Stock Analyst Rating Reiterations → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action All Ratings Strong Buy Buy Hold Sell Rating Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsADVMAdverum Biotechnologies Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. CaufieldSubscribe to MarketBeat All Access for the recommendation accuracy rating$10.45+8.7% $30.00Buy ➝ BuyAMLXAmylyx Pharmaceuticals Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.86-1.9% $8.00Buy ➝ BuyAVXLAnavex Life Sciences Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.88 $40.00Buy ➝ BuyBANDBandwidth Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$21.46-0.3%HoldBIGCBigCommerce Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.46-0.9% $14.00Buy ➝ BuyBNBrookfield Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$44.02-0.5%$45.00 ➝ $46.00Market Perform ➝ Market Perform Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BRLTBrilliant Earth Group Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.71+1.1%$4.00 ➝ $4.00Outperform ➝ OutperformBTAIBioXcel Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.16-6.5% $10.00Buy ➝ BuyCHUYChuy's Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$27.84-6.3% $38.00Outperform ➝ OutperformFIGSFIGS Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingD. TelseySubscribe to MarketBeat All Access for the recommendation accuracy rating$5.72+1.8%$6.00 ➝ $6.00Market Perform ➝ Market PerformFOLDAmicus Therapeutics Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.27-2.2%HoldGGenpact Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$34.21+6.7% $40.00Buy ➝ BuyGHLDGuild Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.50+0.4% $17.00Outperform ➝ OutperformHAEHaemonetics Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$94.19+1.7%HoldHIPOHippo Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$18.42-0.5%$21.00 ➝ $22.00Outperform ➝ OutperformHLVXHilleVax Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. CaufieldSubscribe to MarketBeat All Access for the recommendation accuracy rating$14.23+1.7% $28.00Buy ➝ BuyKZRKezar Life Sciences Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$0.78-4.2% $20.00Buy ➝ BuyLFMDLifeMD Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.60+3.2% $12.00Buy ➝ BuyLPTHLightPath Technologies Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.50+12.4% $3.00Buy ➝ BuyMARAMarathon Digital Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$18.10-7.9%HoldNVMINova Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$191.63-0.8%HoldONTOOnto Innovation Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$219.96+5.5%HoldPARPAR Technology Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$40.87-1.5% $53.00Buy ➝ BuyPHATPhathom Pharmaceuticals Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$10.12+0.3% $28.00Buy ➝ BuyPRQRProQR Therapeutics Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$2.14+7.0% $5.00Buy ➝ BuyQSIQuantum-Si Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. RamakanthSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.78-2.7% $4.00Buy ➝ BuyRLYBRallybio Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$1.95+2.6% $9.00Buy ➝ BuyRNAAvidity Biosciences Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$25.82-4.7% $35.00Buy ➝ BuyRPDRapid7 Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$37.83-0.3%HoldRVNCRevance Therapeutics Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$3.15-26.6%$20.00 ➝ $11.00Overweight ➝ OverweightRXRXRecursion Pharmaceuticals Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.44-2.3% $17.00Buy ➝ BuySERASera Prognostics Reiterated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$9.33-4.7%OutperformSPSCSPS Commerce Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$192.30-0.6% $205.00Buy ➝ BuySTESTERIS Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$226.85+0.4%HoldSTESTERIS Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$226.85+0.4%$220.00 ➝ $225.00Neutral ➝ NeutralSYMSymbotic Reiterated byWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy rating$42.86-4.2%Market PerformTELATELA Bio Reiterated byPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy rating$5.69+15.2%$12.00 ➝ $10.00Overweight ➝ OverweightTTGTTechTarget Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$27.88+0.1% $50.00Buy ➝ BuyTYRATyra Biosciences Reiterated byHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy rating$17.68-0.5% $23.00Buy ➝ BuyUUnity Software Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$22.96-5.0% $31.00Buy ➝ BuyTrump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…UWMCUWM Reiterated byWedbushSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.18-4.4% $7.00Neutral ➝ NeutralUWMCUWM Reiterated byKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy rating$7.18-4.4%$6.00 ➝ $7.00Market Perform ➝ Market PerformVSCOVictoria's Secret & Co. Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$19.84+6.7%$20.00 ➝ $20.00Market Perform ➝ Market PerformVYXNCR Voyix Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$12.40+1.9% $20.00BuyWBDWarner Bros. Discovery Reiterated byNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy rating$8.35+3.9%HoldWMTWalmart Reiterated byTelsey Advisory GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating$60.47+0.0%$68.00 ➝ $68.00Outperform ➝ OutperformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 10:44 AM ET. Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage. Email Address Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
